Causal prophylactic efficacy of atovaquone-proguanil (MalaroneTM) in a human challenge model-Reference-Cited by-同舟云学术

Causal prophylactic efficacy of atovaquone-proguanil (MalaroneTM) in a human challenge model

Published:2001-07 Issue:4 Volume:95 Page:429-432
ISSN:0035-9203
Container-title:Transactions of the Royal Society of Tropical Medicine and Hygiene
language:en
Short-container-title:Transactions of the Royal Society of Tropical Medicine and Hygiene

Author:

Berman J.D.,Nielsen R.,Chulay J.D.,Dowler M.,Kain K.C.,Kester K.E.,Williams J.,Whelen A.C.,Shmuklarsky M.J.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology

Link

http://academic.oup.com/trstmh/article-pdf/95/4/429/5368766/95-4-429.pdf

Reference33 articles.

1. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama P-F-6 strain);Arnold;Journal of Laboratory and Clinical Medicine,1955

2. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum;Basco;American Journal of Tropical Medicine and Hygiene,1995

3. Clinical pharmacology of atovaquone and proguanil hydrochloride;Beerahee;Journal of Travel Medicine,1999

4. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial;Brueckner;Antimicrobial Agents and Chemotherapy,1998

5. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro;Canfield;Experimental Parasitology,1995

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of ivermectin and its metabolites against Plasmodium falciparum liver stages in primary human hepatocytes;Antimicrobial Agents and Chemotherapy;2024-08-07

2. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives;Travel Medicine and Infectious Disease;2023-03

3. Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research;Travel Medicine and Infectious Disease;2022-09

4. Histopathological and ultrastructural assessment of atovaquone-proguanil hydrochloride combination in chronic murine toxoplasmosis;Ultrastructural Pathology;2021-10-01

5. Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations;The American Journal of Tropical Medicine and Hygiene;2020-07-08